Health Canada's final report on the cardiovascular risks of COX-2 selective non-steroidal anti-inflammatory drugs. They state that long term use of the COX-2 selective drugs are associated with increased risk of cardiovascular events when compared to placebo. They recommend the labeling of _all_ NSAIDs to reflect cardiovascular risk but that no data exists to rank such risk.
Report on the Cardiovascular Risks Associated with COX-2 Selective Non-Steroidal Anti-Inflammatory Drugs
skip to main |
skip to sidebar
news stories and sundry information relevant to busy physicians and other health care providers interested in long term care.
Blog Archive
-
▼
2006
(201)
-
▼
June
(38)
- Code status
- AMDA
- Parkinsons
- Considering drug cost
- Dehydration
- When to consider LTC?
- Dental care for seniors : the gaps
- Long term acute care?
- Personal care in Scotland
- Pandemic planning checklist for LTC
- Interactive website for older Canadian drivers
- New Canadian initiative
- Poor standards everywhere ?
- Pressure sores on the rise
- Staffing diversity
- Oral supplements
- Happines and age
- Man found dead in nursing home
- Nursing home violence
- COX-2
- New York
- Moving out of LTC
- START programme
- Muslims and LTC
- Canadian Healthcare Association merges
- the generalist
- antipsychotic drugs
- Culture change in LTC
- Blood glucose testing in LTC
- Irish nursing homes
- Nursing home acquired pneumonia
- Capacity and the frail elderly
- time management
- Seroquel
- Physician shortages
- Sexual assault in nursing home
- Extendicare plans
- Respite care : one solution
-
▼
June
(38)
About Me
No comments:
Post a Comment